Almost 10% of 6,156 European patients with adult-onset diabetes had at least one diabetes-related autoantibody, a study in Diabetes Care found. Of the patients who had an autoantibody, 90.5% had glutamic acid decarboxylase autoantibodies, indicating an eventual need for insulin therapy, researchers said. Many patients with autoimmune diabetes did not exhibit distinct clinical differences from type 2 diabetes patients who did not have autoantibodies.

Related Summaries